Introducing Eyetelligence Ltd, the groundbreaking startup based in Melbourne, Australia, that has recently raised an impressive $12M in funding from Ascertain. Founded by visionary entrepreneur Rainer Grote, Eyetelligence is revolutionizing the field of ophthalmology with its cutting-edge Assure software. Designed to support clinical decision-making, Eyetelligence Assure utilizes advanced AI technology to analyze retinal images for features of glaucoma, referrable diabetic retinopathy, and neovascular AMD. With Eyetelligence, clinicians can now see with certainty and provide enhanced patient care. This innovative software not only draws attention to critical areas in the retinal images but also serves as a visual tool to help patients better understand the need for additional tests. 

The software's traffic light results facilitate clear explanations, leading to increased patient compliance and a greater understanding of the value of further investigations. Eyetelligence Assure's AI models have been meticulously trained using 200,000 peer-reviewed retinal images, ensuring accuracy and reliability. Moreover, the software is compatible with most fundus cameras and operates securely offline, safeguarding patient data privacy. Eyetelligence combines cutting-edge technology, validated research, and user-friendly functionality to empower clinicians and enhance patient outcomes. Experience the future of ophthalmology with Eyetelligence and unlock new levels of precision and patient care.